InvestorsHub Logo
Followers 22
Posts 996
Boards Moderated 0
Alias Born 08/01/2016

Re: None

Wednesday, 07/12/2017 9:25:54 AM

Wednesday, July 12, 2017 9:25:54 AM

Post# of 8449
Bullish statements made in 6-26-17 PR release: As such, KTOV expects that the formal filing of the NDA by the FDA will occur by the end of the 3rd quarter of 2017.
Next paragraph:
Given the excellent results of our phase3 clinical trial were confident that KIT-302 will be approved by the FDA and become a successful treatment for osteoorthritis and hypertension.